Literature DB >> 9627587

Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia.

J O Niu1, U K Munshi, M M Siddiq, L A Parton.   

Abstract

OBJECTIVES: To determine whether endothelin-1 (ET-1) in tracheal aspirates (TA) is a specific marker for acute lung injury in preterm infants with respiratory distress syndrome (RDS) who progress to bronchopulmonary dysplasia (BPD); and to investigate the relationship between TA ET-1 and the proinflammatory cytokines, interleukin-6 (IL-6) and IL-8, as early mediators of BPD. STUDY
DESIGN: We measured TA ET-1, IL-6, and IL-8 levels in preterm infants whose lungs were mechanically ventilated for RDS, categorized into two groups, BPD or non-BPD, on the basis of oxygen requirement at 36 weeks' postconceptional age.
RESULTS: A total of 106 TA samples were obtained from 34 infants with gestational ages ranging from 24 to 28 weeks on days 1, 3, 5, and 7 of life. There was a wide range of ET-1 concentration. TA ET-1 levels were significantly elevated on days 1, 3, and 7 in infants in whom BPD developed, in comparison with the non-BPD group (Mann-Whitney U test: p < 0.01). TA IL-8 levels were elevated on days 1, 3, 5, and 7 in the BPD group (p < 0.01); TA IL-6 levels were elevated (p < 0.05) only on day 5. There was a similarity in pattern of increase of TA ET-1 and TA IL-8 levels in the BPD group, with both being elevated in the first 24 hours of life and through the first week. There was no correlation between ET-1 and IL-8 values.
CONCLUSION: Early significant increase in the TA ET-1 and IL-8 concentrations in preterm infants with acute lung injury correlates with subsequent progression to BPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627587     DOI: 10.1016/s0022-3476(98)70392-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Standardized lung recruitment during high frequency and conventional ventilation: similar pathophysiologic and inflammatory responses in an animal model of respiratory distress syndrome.

Authors:  Ramesh K M Krishnan; Pat A Meyers; Cathy Worwa; Ronald Goertz; Galen Schauer; Mark C Mammel
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

Review 2.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

3.  Safety and efficacy of nitric oxide in chronic lung disease.

Authors:  P L Clark; I I Ekekezie; H A Kaftan; C A Castor; W E Truog
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

4.  Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.

Authors:  David Wolf; Nancy Tseng; Gregory Seedorf; Gates Roe; Steven H Abman; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-13       Impact factor: 5.464

5.  Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Katherine Kuhn; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-19       Impact factor: 5.464

Review 6.  Cromolyn sodium for the prevention of chronic lung disease in preterm infants.

Authors:  Geraldine Ng; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2017-01-23

7.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

8.  Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Gates Roe; Steven H Abman
Journal:  Pediatr Res       Date:  2012-11-30       Impact factor: 3.756

Review 9.  IL-17 in neonatal health and disease.

Authors:  Shelley M Lawrence; Jessica Lauren Ruoss; James L Wynn
Journal:  Am J Reprod Immunol       Date:  2017-12-15       Impact factor: 3.886

Review 10.  Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia.

Authors:  Catheline Hocq; Laetitia Vanhoutte; Axelle Guilloteau; Anna Claudia Massolo; Bénédicte Van Grambezen; Kate Carkeek; Fiammetta Piersigilli; Olivier Danhaive
Journal:  Pediatr Res       Date:  2021-03-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.